BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10358194)

  • 1. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
    Gasque P; Singhrao SK; Neal JW; Wang P; Sayah S; Fontaine M; Morgan BP
    J Immunol; 1998 Apr; 160(7):3543-54. PubMed ID: 9531317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
    Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
    J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
    Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
    Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines.
    Burg M; Martin U; Rheinheimer C; Köhl J; Bautsch W; Böttger EC; Klos A
    J Immunol; 1995 Nov; 155(9):4419-26. PubMed ID: 7594603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
    Richard S; Farrell CA; Shaw AS; Showell HJ; Connelly PA
    J Immunol; 1994 Mar; 152(5):2479-87. PubMed ID: 8133059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells.
    Crass T; Raffetseder U; Martin U; Grove M; Klos A; Köhl J; Bautsch W
    Eur J Immunol; 1996 Aug; 26(8):1944-50. PubMed ID: 8765043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed C3a receptor antibodies from phage display libraries.
    Hawlisch H; Frank R; Hennecke M; Baensch M; Sohns B; Arseniev L; Bautsch W; Kola A; Klos A; Köhl J
    J Immunol; 1998 Mar; 160(6):2947-58. PubMed ID: 9510199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
    Fukuoka Y; Ember JA; Hugli TE
    Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood- and skin-derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin-sensitive signal transduction pathway.
    Zwirner J; Götze O; Moser A; Sieber A; Begemann G; Kapp A; Elsner J; Werfel T
    Eur J Immunol; 1997 Sep; 27(9):2317-22. PubMed ID: 9341775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
    Proctor LM; Moore TA; Monk PN; Sanderson SD; Taylor SM; Woodruff TM
    Int Immunopharmacol; 2009 Jun; 9(6):800-6. PubMed ID: 19285573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro.
    Liu F; Gou R; Huang J; Fu P; Chen F; Fan WX; Huang YQ; Zang L; Wu M; Qiu HY; Wei DP
    Chin Med J (Engl); 2011 Dec; 124(23):4039-45. PubMed ID: 22340339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.